Michael A. Bookman

Follow

Generating author description...

All published works

Action	Title	Year	Authors
+ PDF Chat	Speeding up the Evaluation of New Agents in Cancer	2008	Mahesh Parmar F. M.- S. Barthel Matthew R. Sydes Ruth E. Langley Richard Kaplan E. Eisenhauer Mark F. Brady Nicholas D. James Michael A. Bookman Ann Marie Swart

Common Coauthors

Coauthor	Papers Together
Ruth E. Langley	1
Mahesh Parmar	1
Nicholas D. James	1
F. M.- S. Barthel	1
Richard Kaplan	1
Matthew R. Sydes	1
Mark F. Brady	1
Patrick Royston	1
Wendi Qian	1
E. Eisenhauer	1
Ann Marie Swart	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+	New designs for the selection of treatments to be tested in randomized clinical trials	1994	Richard Simon Peter F. Thall Susan S. Ellenberg	1
+	Criteria for the Validation of Surrogate Endpoints in Randomized Experiments	1998	Marc Buyse Geert Molenberghs	1
+	Phase II trials in the EORTC	1997	The protocol review committee the data center the research and treatment division the new drug development office	1
+	The Phase III Trial in the Era of Targeted Therapy: Unraveling the “Go or No Go” Decision	2003	Thomas G. Roberts Thomas J. Lynch Bruce A. Chabner	1
+	Novel designs for multi‐arm clinical trials with survival outcomes with an application in ovarian cancer	2003	Patrick Royston Mahesh Parmar Wendi Qian	1
+	Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: Applications and Practical Considerations	2006	Heinz Schmidli Frank Bretz Amy Racine Willi Maurer	1